Objectives

After participating in this educational activity, attendees should be able to:

1| Compare two patient cases involving pregnancies complicated by life-limiting fetal anomalies
2| Recognize the ethical dilemmas encountered in these cases
3| Construct an ethics framework for approaching these cases in the future

Presenter(s): 

Kathryn Delaney, MD, MA
Perinatologist
Ob/Gyn-Maternal Fetal Medicine

Peter A. DePergola II, PhD, MTS, HEC-C, CT
Chief Ethics Officer, Baystate Health
 

 

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Kathryn Delaney, MD, MASpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Peter A. DePergola II, PhD, MTS, HEC-C, CTSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
03/27/2025 - 8:00am to 9:00am EDT
Location: 
Lundy Board Room & Zoom
759 Chestnut St
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.